SCHEMBL8906558

SCHEMBL8906558

NC(CS)C([O])=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5555288 1.00
Cysteine SCHEMBL9780171 0.79 PTGS1 (0.94)
Cysteine SCHEMBL9780174 0.79 PTGS1 (0.94)
Cysteine SCHEMBL4864416 0.77 PTGS1 (0.55)
Cysteine SCHEMBL28081717 0.77 PTGS1 (0.89)
Cysteine SCHEMBL28081716 0.77 PTGS1 (0.89)
Cysteine SCHEMBL4864408 0.77 PTGS1 (0.55)
Cysteine SCHEMBL95110 0.75
Cysteine SCHEMBL4289403 0.75
SCHEMBL16033448 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1296380-C Pharmaceutical compounds NICOX SA (FR) 2007-01-24 CN disclosed
US-5698585-A FOR SENILE CATARACT CAUSED BY OXIDATION DISORDER; VISION DEFECTS KIKKOMAN CORPORATION (JP) 1997-12-16 US disclosed
EP-0737476-A2 A pharmaceutical preparation containing a 3-(2H)-furanone derivative for prevention and/or treatment of cataracts KIKKOMAN CORPORATION (JP) 1996-10-16 EP disclosed
US-4914206-A ANTIBIOTICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1990-04-03 US disclosed
EP-0226896-A2 Lankacidin derivatives and production thereof Takeda Chemical Industries, Ltd. (JP) 1987-07-01 EP disclosed